Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Sees Large Decrease in Short Interest

by · The Cerbat Gem

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT – Get Free Report) was the recipient of a significant drop in short interest during the month of April. As of April 30th, there was short interest totaling 408 shares, a drop of 47.3% from the April 15th total of 774 shares. Based on an average daily volume of 2,035 shares, the short-interest ratio is currently 0.2 days. Approximately 0.1% of the company’s stock are sold short.

Institutional Investors Weigh In On Innovator IBD Breakout Opportunities ETF

Institutional investors and hedge funds have recently made changes to their positions in the company. Osaic Holdings Inc. increased its position in shares of Innovator IBD Breakout Opportunities ETF by 39.7% during the second quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after acquiring an additional 597 shares in the last quarter. Comprehensive Wealth Management LLC increased its position in shares of Innovator IBD Breakout Opportunities ETF by 60.5% during the third quarter. Comprehensive Wealth Management LLC now owns 10,544 shares of the company’s stock valued at $411,000 after acquiring an additional 3,976 shares in the last quarter. Finally, Susquehanna International Group LLP increased its position in shares of Innovator IBD Breakout Opportunities ETF by 42.6% during the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock valued at $1,020,000 after acquiring an additional 7,817 shares in the last quarter.

Innovator IBD Breakout Opportunities ETF Stock Down 1.2%

Shares of BOUT stock traded down $0.53 during trading hours on Monday, hitting $45.35. 6,253 shares of the company’s stock traded hands, compared to its average volume of 5,048. The stock’s fifty day simple moving average is $41.89 and its two-hundred day simple moving average is $39.48. Innovator IBD Breakout Opportunities ETF has a 12-month low of $34.57 and a 12-month high of $47.00. The stock has a market cap of $15.87 million, a price-to-earnings ratio of 28.69 and a beta of 1.05.

About Innovator IBD Breakout Opportunities ETF

(Get Free Report)

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.

Read More